These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

890 related items for PubMed ID: 2110013

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure.
    Duffel MW, Ing IS, Segarra TM, Dixson JA, Barfknecht CF, Schoenwald RD.
    J Med Chem; 1986 Aug; 29(8):1488-94. PubMed ID: 3735316
    [Abstract] [Full Text] [Related]

  • 43. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL, Larsson LI, McLaren JW, Brubaker RF.
    Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424
    [Abstract] [Full Text] [Related]

  • 44. Topical ocular hypotensive activity and ocular penetration of dichlorphenamide sodium in rabbits.
    Lotti VJ, Schmitt CJ, Gautheron PD.
    Graefes Arch Clin Exp Ophthalmol; 1984 Jan; 222(1):13-9. PubMed ID: 6510719
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
    Hiett JA, Dockter CA.
    Optom Clin; 1992 Jan; 2(4):97-112. PubMed ID: 1286242
    [Abstract] [Full Text] [Related]

  • 48. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
    Sharif NA, McLaughlin MA, Kelly CR, Katoli P, Drace C, Husain S, Crosson C, Toris C, Zhan GL, Camras C.
    Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
    [Abstract] [Full Text] [Related]

  • 49. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT.
    J Med Chem; 1999 Jul 15; 42(14):2641-50. PubMed ID: 10411484
    [Abstract] [Full Text] [Related]

  • 50. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
    Yamazaki Y, Miyamoto S, Sawa M.
    Jpn J Ophthalmol; 1994 Jul 15; 38(1):92-6. PubMed ID: 7933704
    [Abstract] [Full Text] [Related]

  • 51. Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits.
    Reitsamer HA, Bogner B, Tockner B, Kiel JW.
    Invest Ophthalmol Vis Sci; 2009 May 15; 50(5):2301-7. PubMed ID: 19182250
    [Abstract] [Full Text] [Related]

  • 52. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G, Carreiro S, Anderson S, Gukasyan H, Sartnurak S, Younis H, Gale D, Xiang C, Wells P, Dinh D, Almaden C, Fortner J, Toris C, Niesman M, Lafontaine J, Krauss A.
    Exp Eye Res; 2011 Sep 15; 93(3):256-64. PubMed ID: 21376717
    [Abstract] [Full Text] [Related]

  • 53. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
    Vanlandingham BD, Maus TL, Brubaker RF.
    Ophthalmology; 1998 Aug 15; 105(8):1537-40. PubMed ID: 9709770
    [Abstract] [Full Text] [Related]

  • 54. Ocular pharmacology of methazolamide analogs: distribution in the eye and effects on pressure after topical application.
    Maren TH, Bar-Ilan A, Caster KC, Katritzky AR.
    J Pharmacol Exp Ther; 1987 Apr 15; 241(1):56-63. PubMed ID: 3106616
    [Abstract] [Full Text] [Related]

  • 55. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
    Scozzafava A, Briganti F, Mincione G, Menabuoni L, Mincione F, Supuran CT.
    J Med Chem; 1999 Sep 09; 42(18):3690-700. PubMed ID: 10479300
    [Abstract] [Full Text] [Related]

  • 56. A clinical trial of MK-507, Trusopt, for raised intraocular pressure--the Australian experience.
    Gillies WE, Brooks AM.
    Aust N Z J Ophthalmol; 1996 May 09; 24(2):111-5. PubMed ID: 9199740
    [Abstract] [Full Text] [Related]

  • 57. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.
    Renzi G, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2000 Apr 03; 10(7):673-6. PubMed ID: 10762051
    [Abstract] [Full Text] [Related]

  • 58. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
    Grove J, Gautheron P, Plazonnet B, Sugrue MF.
    J Ocul Pharmacol; 1988 Apr 03; 4(4):279-90. PubMed ID: 3246565
    [Abstract] [Full Text] [Related]

  • 59. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
    Sugrue MF.
    Prog Retin Eye Res; 2000 Jan 03; 19(1):87-112. PubMed ID: 10614682
    [Abstract] [Full Text] [Related]

  • 60. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A, Prusakiewicz JJ, Oswald J, Spencer E, Lou Z, Cohen ML, Rashidzadeh H, Josiah S.
    Exp Eye Res; 2019 Dec 03; 189():107836. PubMed ID: 31626797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.